文献速递糖尿病肥胖与代谢综合征

社区动员或手机短信预防和控制孟加拉国2型糖尿病及中间高血糖(DMagic):整群随机对照试验

Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial.
PubMed 文献 · Lancet Diabetes Endocrinol · 2019-02-04

DMagic试验在孟加拉国96个村庄比较参与式社区动员、手机短信和常规护理对2型糖尿病和中间高血糖的影响。手机短信无显著效果。

要点

  • 社区动员可大幅降低2型糖尿病和中间高血糖的联合患病率。
  • 社区动员可降低中间高血糖人群2年内进展为糖尿病的风险。
  • 手机短信干预未显著改善糖尿病相关结局。

核心结论

  • 社区动员基于参与式学习与行动可有效预防孟加拉国农村人群的2型糖尿病。
  • 手机短信干预虽提高知识意识,但未改变疾病结局。

研究设计与样本

  • 干预包括参与式社区动员(18次月度小组会议)、手机短信(14个月内每周两次语音消息)和常规护理。
  • 主要结局为总体人群2型糖尿病和中间高血糖的联合患病率,以及基线中间高血糖人群2年糖尿病累积发病率。

主要发现

  • 社区动员的增量成本效果比为每预防一例中间高血糖或2型糖尿病316国际美元,每预防一例中间高血糖人群进展为2型糖尿病6518国际美元。

临床怎么用

  • 在农村社区可推广参与式社区动员策略以预防2型糖尿病。
  • 手机短信干预不宜作为单独预防措施。

局限性

  • 研究仅针对孟加拉国农村人群,外推需谨慎。
  • 手机短信干预未显示效果,可能与其设计或实施有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Strategies are needed to prevent and control type 2 diabetes and intermediate hyperglycaemia, which together affect roughly a third of adults in Bangladesh. We aimed to assess the effects of mHealth and community mobilisation on the prevalence of intermediate hyperglycaemia and diabetes among the general adult population in rural Bangladesh, and to assess the effect of these interventions on the incidence of type 2 diabetes among people with intermediate hyperglycaemia within the study population. METHODS: DMagic was a three-arm, cluster-randomised trial of participatory community mobilisation, mHealth mobile phone messaging, and usual care (control) in 96 villages (population roughly 125 000) in Bangladesh. Community mobilisation involved 18 monthly group meetings, led by lay facilitators, applying a participatory learning and action (PLA) cycle focused on diabetes prevention and control. mHealth involved twice-weekly voice messages over 14 months promoting behaviour change to reduce diabetes risk. The primary outcomes were the combined prevalence of type 2 diabetes and intermediate hyperglycaemia in the overall population at the end of the intervention implementation period, and 2-year cumulative incidence of type 2 diabetes in a cohort with intermediate hyperglycaemia at baseline. Primary outcomes were assessed through fasting blood glucose concentrations and 2-h oral glucose tolerance tests among a cross-section of adults aged 30 years and older and a cohort of individuals identified with intermediate hyperglycaemia. Prevalence findings are based on a cross-sectional survey at the end of the study; incidence findings are based on 2-year follow-up survey of a cohort of individuals identified with intermediate hyperglycaemia through a cross-sectional survey at baseline. We also assessed the cost-effectiveness of the interventions. This trial is registered with the ISRCTN registry, number ISRCTN41083256, and is completed. FINDINGS: The study took place between June 27, 2015, and June 28, 2018, with the PLA intervention running in 32 villages from June, 2016, to December, 2017, and the mHealth intervention running in 32 villages from Oct 21, 2016, to Dec 24, 2017. End-of study prevalence was assessed in 11 454 individuals and incidence in 2100 individuals. There was a large reduction in the combined prevalence of type 2 diabetes and intermediate hyperglycaemia in the PLA group compared with the control group at the end of the study (adjusted [for stratification, clustering, and wealth] odds ratio [aOR] 0·36 [0·27-0·48]), with an absolute reduction of 20·7% (95% CI 14·6-26·7). Among 2470 adults with intermediate hyperglycaemia at baseline, 2100 (85%) were followed-up at 2 years. The 2-year cumulative incidence of diabetes in this cohort was significantly lower in the PLA group compared with control (aOR 0·39, 0·24-0·65), representing an absolute incidence reduction of 8·7% (3·5-14·0). There was no evidence of effect of mHealth on combined prevalence of intermediate hyperglycaemia and diabetes (aOR 0·93, 0·74-1·16) or the incidence of diabetes (1·02, 0·73-1·43). The incremental cost-effectiveness ratios for PLA were INT$316 per case of intermediate hyperglycaemia or type 2 diabetes prevented and $6518 per case of type 2 diabetes prevented among individuals with intermediate hyperglycaemia. INTERPRETATION: Our data provide strong evidence to support the use of community mobilisation based on PLA to prevent type 2 diabetes in this rural Bangladeshi population. Despite raising knowledge and awareness of diabetes, the mHealth intervention did not change disease outcomes in our population. Replication studies in other populations should be a priority. FUNDING: UK Medical Research Council.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Fottrell E, Ahmed N, Morrison J, et al. Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial. Lancet Diabetes Endocrinol. 2019. PMID: 30733182. doi:10.1016/S2213-8587(19)30001-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。